{"id":61637,"date":"2024-03-03T08:58:06","date_gmt":"2024-03-03T08:58:06","guid":{"rendered":"https:\/\/medsname.com\/glynase-mf\/"},"modified":"2026-05-08T09:15:21","modified_gmt":"2026-05-08T09:15:21","slug":"glynase-mf","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/glynase-mf\/","title":{"rendered":"Glynase-MF"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Glynase-MF?<\/h3>\n<p style=\"margin:0;\"><strong>Glynase-MF<\/strong> este un comprimat cu doz\u0103 fix\u0103 care con\u021bine <strong>Glipizide (5 mg)<\/strong> \u0219i <strong>metformin (500 mg)<\/strong> pentru tratamentul <strong>diabetului de tip 2<\/strong>. It combines two complementary mechanisms in a single tablet: metformin reduces the liver&rsquo;s glucose output and improves insulin sensitivity, while glipizide stimulates the pancreas to release more insulin. Usual dose is one tablet twice daily with breakfast and dinner. Typical HbA1c reduction: <strong>1,5\u20132,0 puncte procentuale<\/strong>. Main side effects: GI upset from metformin (first 1&ndash;2 weeks) and hypoglycaemia from the sulfonylurea. Glipizide has inactive metabolites and a shorter duration than glibenclamide &mdash; a safer sulfonylurea profile for most patients. Avoid in severe renal impairment (eGFR &lt; 30), decompensated heart failure, acute illness with dehydration, and sulfa allergy.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">What Is Glynase-MF?<\/h2>\n<p>Glynase-MF is a <strong>medicament antidiabetic oral cu doz\u0103 fix\u0103 combinat\u0103 (FDC)<\/strong> care con\u021bine dou\u0103 substan\u021be active: <strong>Glipizide (5 mg)<\/strong> \u0219i <strong>metformin hidroclorur\u0103 (500 mg)<\/strong>, fabricat de USV Pharma. Disponibil \u00een cutii cu 30, 60, 90 sau 180 de comprimate.<\/p>\n<p>Combination tablets simplify the regimen (one tablet instead of two), improve adherence, and are typically less expensive than the two components bought separately. Glynase-MF is usually prescribed when metformin monotherapy is not achieving HbA1c targets.<\/p>\n<h2 class=\"wp-block-heading\">How Does Glynase-MF Work?<\/h2>\n<p>Cele dou\u0103 componente atac\u0103 hiperglicemia din unghiuri diferite \u2014 de aceea terapia combinat\u0103 este mai eficient\u0103 dec\u00e2t cre\u0219terea dozei unuia dintre medicamente separat:<\/p>\n<ul>\n<li><strong>Metformin\u0103<\/strong> \u2014 reduce produc\u021bia hepatic\u0103 de glucoz\u0103 (cu p\u00e2n\u0103 la o treime), \u00eembun\u0103t\u0103\u021be\u0219te sensibilitatea la insulin\u0103 la nivel muscular \u0219i adipos \u0219i \u00eencetine\u0219te modest absorb\u021bia intestinal\u0103 a glucozei. Nu stimuleaz\u0103 <em>prime\u0219te,<\/em> eliberarea de insulin\u0103 \u0219i nu provoac\u0103 hipoglicemie prin sine.<\/li>\n<li><strong>Glipizide<\/strong> \u2014 \u00eenchide canalele de potasiu dependente de ATP din celulele beta pancreatice, depolariz\u00e2ndu-le \u0219i declan\u0219\u00e2nd eliberarea de insulin\u0103 <strong>mediat\u0103 de calciu<\/strong>. Acest mecanism func\u021bioneaz\u0103 doar c\u00e2t timp celulele beta mai produc insulin\u0103 (diabet zaharat de tip 2 \u00een stadiu timpuriu sau intermediar).<\/li>\n<\/ul>\n<p>\u00cempreun\u0103, cele dou\u0103 mecanisme determin\u0103 o sc\u0103dere a HbA1c de <strong>1,5\u20132,0 puncte procentuale<\/strong>, semnificativ mai mare dec\u00e2t monoterapia cu metformin\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Doza \u0219i administrare<\/h2>\n<p><strong>Doza ini\u021bial\u0103:<\/strong> One tablet of Glynase-MF with the main meal (breakfast). If glycaemia is not controlled after 2&ndash;4 weeks, increase to one tablet twice daily &mdash; with breakfast and dinner.<\/p>\n<ul>\n<li><strong>Lua\u021bi \u00een timpul mesei sau imediat dup\u0103<\/strong> \u2014 reduce efectele secundare gastrointestinale ale metforminei \u0219i sincronizeaz\u0103 ac\u021biunea sulfonilureei cu cre\u0219terea postprandial\u0103 a glucozei.<\/li>\n<li><strong>Titra\u021bi lent.<\/strong> Cre\u0219terile treptate ale dozei reduc at\u00e2t tulbur\u0103rile gastrointestinale, c\u00e2t \u0219i riscul de hipoglicemie.<\/li>\n<li><strong>Nu dubla\u021bi doza ratat\u0103.<\/strong> Omite\u021bi doza ratat\u0103; lua\u021bi urm\u0103toarea la ora obi\u0219nuit\u0103.<\/li>\n<li><strong>\u00cenainte de interven\u021bii chirurgicale, administrare de contrast IV sau boli acute<\/strong> \u2014 \u00eentrerupe\u021bi medicamentul \u0219i contacta\u021bi medicul dumneavoastr\u0103.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>De la componenta de metformin\u0103 (de obicei \u00een primele 1\u20132 s\u0103pt\u0103m\u00e2ni):<\/strong><\/p>\n<ul>\n<li>Diaree, grea\u021b\u0103, crampe abdominale, flatulen\u021b\u0103<\/li>\n<li>Gust metalic \u00een gur\u0103<\/li>\n<li>Pierderea apetitului<\/li>\n<\/ul>\n<p><strong>De la componenta sulfonilureic\u0103:<\/strong><\/p>\n<ul>\n<li><strong>Hipoglicemie<\/strong> \u2014 tremur\u0103turi, transpira\u021bie, palpita\u021bii, foame, confuzie. Trata\u021bi cu 15 g de carbohidra\u021bi cu ac\u021biune rapid\u0103. Riscul este mai mare la persoanele \u00een v\u00e2rst\u0103, dup\u0103 omisiunea meselor sau \u00een cazul insuficien\u021bei renale.<\/li>\n<li>Cre\u0219tere modest\u0103 \u00een greutate (1\u20133 kg)<\/li>\n<li>Erup\u021bii cutanate ocazionale<\/li>\n<\/ul>\n<p><strong>Pu\u021bin frecvente, dar grave:<\/strong><\/p>\n<ul>\n<li>Acidoz\u0103 lactic\u0103 (de la metformin\u0103) \u2014 foarte rar\u0103, aproape \u00eentotdeauna \u00een contextul insuficien\u021bei renale acute, septicemiei sau hipoxiei<\/li>\n<li>Deficit de vitamina B12 (la utilizarea pe termen lung a metforminei) \u2014 control anual recomandat<\/li>\n<li>Hipoglicemie sever\u0103 \u2014 poate necesita interven\u021bie medical\u0103, \u00een special la persoanele \u00een v\u00e2rst\u0103 sau cu insuficien\u021b\u0103 renal\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<p><strong>Factori care cresc riscul de hipoglicemie:<\/strong> insulin\u0103, alte antidiabetice, alcool (\u00een special consumul excesiv), trimetoprim\/sulfametoxazol, fluconazol, claritromicin\u0103, inhibitori ACE, salicila\u021bi \u00een doze mari, beta-blocante neselective (care de asemenea mascheaz\u0103 simptomele hipoglicemiei), IMAO.<\/p>\n<p><strong>Cre\u0219te riscul de acidoz\u0103 lactic\u0103 (metformin\u0103):<\/strong> contrast iodat IV, inhibitori ai anhidrazei carbonice (acetazolamid\u0103, topiramat), medicamente cationice (cimetidin\u0103, dolutegravir, ranolazin\u0103).<\/p>\n<p><strong>Reduc efectul hipoglicemiant:<\/strong> corticoesteroizi, diuretice tiazidice, hormoni tiroidieni, fenitoin\u0103, rifampicin\u0103, antipsihotice atipice, contraceptive orale.<\/p>\n<h2 class=\"wp-block-heading\">Who Should Not Take Glynase-MF?<\/h2>\n<ul>\n<li>Diabet zaharat tip 1, cetoacidoz\u0103 diabetic\u0103<\/li>\n<li>Insuficien\u021b\u0103 renal\u0103 sever\u0103 (TFG &lt; 30 mL\/min\/1,73 m\u00b2)<\/li>\n<li>Insuficien\u021b\u0103 cardiac\u0103 acut\u0103 sau instabil\u0103<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103<\/li>\n<li>Alergie la sulfonamide (sulfa)<\/li>\n<li>Boal\u0103 acut\u0103 cu risc de hipoxie tisular\u0103 \u2014 septicemie, insuficien\u021b\u0103 respiratorie, infarct miocardic recent<\/li>\n<li>Sarcina \u0219i al\u0103ptarea \u2014 insulina este preferat\u0103<\/li>\n<li>\u00cenainte \u0219i la 48 de ore dup\u0103 administrarea de contrast iodat IV (dac\u0103 TFG &lt; 60)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>Store Glynase-MF below 25&deg;C in a dry place, in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Is Glynase-MF the same as taking metformin and glipizide separately?<\/h3>\n<p>Din punct de vedere clinic, da \u2014 combina\u021bia cu doz\u0103 fix\u0103 furnizeaz\u0103 acelea\u0219i substan\u021be active \u00een acelea\u0219i doze ca cele dou\u0103 comprimate luate \u00eempreun\u0103. Avantajul const\u0103 \u00een mai pu\u021bine comprimate, o mai bun\u0103 adheren\u021b\u0103 \u0219i, de obicei, un cost mai mic. Dezavantajul este flexibilitatea redus\u0103 a dozei: dac\u0103 oricare component\u0103 necesit\u0103 ajustare, combina\u021bia cu doz\u0103 fix\u0103 trebuie \u00eenlocuit\u0103 cu comprimatele separate.<\/p>\n<h3 class=\"wp-block-heading\">When is Glynase-MF usually added to a diabetes regimen?<\/h3>\n<p>C\u00e2nd monoterapia cu metformin\u0103 la doza maxim\u0103 tolerat\u0103 nu mai controleaz\u0103 HbA1c. Majoritatea ghidurilor (ADA, EASD, NICE) recomand\u0103 ad\u0103ugarea unui al doilea agent c\u00e2nd HbA1c este &gt; 7,5% doar cu metformin\u0103. O sulfoniluree este o op\u021biune utilizat\u0103 pe scar\u0103 larg\u0103 ca tratament de linia a doua, deoarece este ieftin\u0103 \u0219i eficient\u0103, de\u0219i inhibitorii DPP-4 \u0219i inhibitorii SGLT-2 sunt acum prefera\u021bi la persoanele cu comorbidit\u0103\u021bi cardiovasculare sau renale.<\/p>\n<h3 class=\"wp-block-heading\">Can Glynase-MF cause low blood sugar (hypoglycaemia)?<\/h3>\n<p>Yes &mdash; because it contains a sulfonylurea. Skipping meals, unusual exercise, alcohol, and certain drug interactions raise the risk. Always take Glynase-MF with food and carry fast-acting carbohydrate. Severe or prolonged hypoglycaemia needs medical review.<\/p>\n<h3 class=\"wp-block-heading\">Will Glynase-MF cause weight gain?<\/h3>\n<p>O cre\u0219tere modest\u0103 \u00een greutate (1\u20133 kg) este frecvent\u0103 din cauza componentei de sulfoniluree. Metformina este neutr\u0103 din punct de vedere al greut\u0103\u021bii sau u\u0219or reductoare, astfel \u00eenc\u00e2t combina\u021bia cu doz\u0103 fix\u0103 provoac\u0103 de obicei o cre\u0219tere mai mic\u0103 dec\u00e2t monoterapia cu sulfoniluree.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol while taking Glynase-MF?<\/h3>\n<p>Consumul moderat de alcool \u00een timpul mesei este \u00een general sigur. Evita\u021bi consumul excesiv de alcool \u0219i alcoolul pe stomacul gol \u2014 ambele cresc riscul de hipoglicemie (datorit\u0103 sulfonilureei) \u0219i riscul de acidoz\u0103 lactic\u0103 (datorit\u0103 metforminei).<\/p>\n<h3 class=\"wp-block-heading\">Mai trebuie s\u0103-mi verific glicemia?<\/h3>\n<p>Da, \u00een special \u00een primele 2\u20134 s\u0103pt\u0103m\u00e2ni, dup\u0103 modific\u0103ri de doz\u0103 sau \u00een timpul bolii. HbA1c ar trebui verificat\u0103 la fiecare 3\u20136 luni.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Glynase-MF online?<\/h3>\n<p>You can order Glynase-MF (5 mg + 500 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n<h2 class=\"wp-block-heading\">Medicamente \u00eenrudite pentru Diabet<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glycomet-sr\/\">Glycomet SR \u2014 Metformin cu eliberare prelungit\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amaryl\/\">Amaryl \u2014 Glimepirid\u0103 1\/2\/4 mg (Sanofi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/januvia\/\">Januvia \u2014 Sitagliptin\u0103 (inhibitor DPP-4)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/jardiance-empagliflozin\/\">Jardiance \u2014 Empagliflozin\u0103 (inhibitor SGLT-2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/forxiga-dapagliflozin\/\">Forxiga \u2014 Dapagliflozin (inhibitor SGLT-2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/janumet\/\">Janumet \u2014 Combina\u021bie Sitagliptin + Metformin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/diabetes-medication\/\"><strong>Vizualiza\u021bi toate Medicamentele pentru Diabet<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are doar scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui specialist calificat. Combina\u021biile de sulfoniluree + metformin pot provoca hipoglicemie \u0219i (rar) acidoz\u0103 lactic\u0103 \u2014 utiliza\u021bi \u00eentotdeauna sub supraveghere medical\u0103, cu monitorizare regulat\u0103 a glicemiei, func\u021biei renale \u0219i nivelului de vitamina B12.<\/div>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-diabetes-starter-pack\">If you want the standard ADA\/EASD step-up sequence \u2014 metformin first, then metformin + sulfonylurea \u2014 bundled in one shipment, our <a href='\/ro\/diabetes-starter-pack\/'>Pachetul de Start pentru Diabet (Glycomet SR 1000 mg + Glycomet-GP)<\/a> offers both molecules at matched 1, 3, or 6-month tiers, sourced from the most-prescribed Glycomet line.<\/p>\n<p class=\"medsbase-link-boost-2026-05-08\" data-marker=\"mb-link-boost-glycomet-sr\">When the glipizide component of <a href=\"https:\/\/medsbase.com\/ro\/glynase-mf\/\">Glynase-MF<\/a> is discontinued and metformin monotherapy continued, <a href=\"https:\/\/medsbase.com\/ro\/glycomet-sr\/\">Glycomet SR (clorhidrat de metformin\u0103 500\u20131000 mg SR)<\/a> is the natural extended-release step-down option, maintaining the same insulin-sensitising mechanism without the sulphonylurea component.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/rami-race\/\">Rami Race<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lipvas\/\">Thyronorm<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/hyloric\/\">Hyloric<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glynase-xl\/\">Glynase Xl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/metolar\/\">Metolar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Controlizeaz\u0103 glicemia<br \/>\n\u2705 Gestioneaz\u0103 eficient diabetul<br \/>\n\u2705 Combats insulin resistance<br \/>\n\u2705 Reduce nivelul de glucoz\u0103<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te sensibilitatea la insulin\u0103<\/p>\n<p>Glynase-MF contains Glipizide and Metformin.<\/p>","protected":false},"featured_media":61638,"comment_status":"closed","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3257,5073,3255],"class_list":{"0":"post-61637","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-glipizide","11":"product_tag-glynase-mf","12":"product_tag-metformin","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/61637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=61637"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/61638"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=61637"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=61637"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=61637"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=61637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}